| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 141 |
| 1 | ONABOTULINUMTOXINA | 60 |
| 2 | ALBUTEROL SULFATE | 47 |
| 3 | ERGOCALCIFEROL | 37 |
| 4 | FLUTICASONE PROPIONATE | 34 |
| 5 | OMEPRAZOLE MAGNESIUM | 33 |
| 6 | BOTULINUM TOXIN TYPE A | 30 |
| 7 | ACETAMINOPHEN | 27 |
| 8 | SODIUM CHLORIDE | 27 |
| 9 | CETIRIZINE HYDROCHLORIDE | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | 1 | 0.5000 |
| 1 | MULTIPLE VITAMINS INJECTION | 4 | 0.0244 |
| 2 | PRILOCAINE HYDROCHLORIDE | 1 | 0.0062 |
| 3 | FLUTEMETAMOL F-18 | 3 | 0.0058 |
| 4 | NITAZOXANIDE | 2 | 0.0057 |
| 5 | GARADACIMAB | 4 | 0.0052 |
| 6 | SETMELANOTIDE | 1 | 0.0035 |
| 7 | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10% | 1 | 0.0026 |
| 8 | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | 1 | 0.0025 |
| 9 | BOTULINUM TOXIN TYPE A | 30 | 0.0023 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 141 |
| 1 | Acetylcholine Release Inhibitor [EPC] | 93 |
| 2 | Neuromuscular Blocker [EPC] | 93 |
| 3 | Corticosteroid [EPC] | 56 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 56 |
| 5 | Benzodiazepine [EPC] | 32 |
| 6 | Proton Pump Inhibitor [EPC] | 32 |
| 7 | Osmotic Laxative [EPC] | 31 |
| 8 | Catecholamine [EPC] | 24 |
| 9 | alpha-Adrenergic Agonist [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 1 | CD3-directed Antibody [EPC] | 1 | 0.0014 |
| 2 | Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] | 2 | 0.0010 |
| 3 | Radioactive Diagnostic Agent [EPC] | 3 | 0.0010 |
| 4 | Acetylcholine Release Inhibitor [EPC] | 93 | 0.0009 |
| 5 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |
| 6 | Neurokinin 3 Receptor Antagonist [EPC] | 2 | 0.0009 |
| 7 | Leukotriene Receptor Antagonist [EPC] | 18 | 0.0006 |
| 8 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 2 | 0.0005 |
| 9 | Endoglycosidase [EPC] | 1 | 0.0005 |